Sale!

FOXC2 Gene Lymphedema-Distichiasis Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FOXC2 gene lymphedema-distichiasis syndrome genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FOXC2 gene, which are linked to the development of lymphedema-distichiasis syndrome (LDS). LDS is a rare genetic disorder characterized by swelling (lymphedema) primarily in the legs, due to fluid accumulation, and distichiasis, the presence of extra eyelashes that may irritate the eye. This test is crucial for individuals who have a family history of LDS or exhibit symptoms of the condition, as early detection can lead to better management and treatment options.

The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic variations in the FOXC2 gene that may be responsible for the syndrome. The cost of the test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. By confirming a diagnosis of lymphedema-distichiasis syndrome, affected individuals can seek appropriate medical interventions, such as physical therapy, surgery, or specialized eye care, to manage symptoms and improve quality of life.

Description

FOXC2 Gene Lymphedema-distichiasis syndrome Genetic Test

Test Name: FOXC2 Gene Lymphedema-distichiasis syndrome Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FOXC2 Gene Lymphedema-distichiasis syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXC2 Gene Lymphedema-distichiasis syndrome NGS Genetic DNA Test gene FOXC2

Test Details:

The FOXC2 gene is a gene that provides instructions for making a protein called forkhead box C2. This protein is involved in the development of various tissues and organs, including the lymphatic system. Mutations in the FOXC2 gene can lead to a condition called lymphedema-distichiasis syndrome. Lymphedema-distichiasis syndrome is a rare genetic disorder characterized by the abnormal swelling of the limbs due to impaired lymphatic drainage. Distichiasis refers to the presence of extra eyelashes along the eyelid margin. Other features of this syndrome may include heart defects, cleft palate, and varicose veins.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the FOXC2 gene. It is a powerful tool that can detect mutations or variations in the DNA sequence of genes associated with various genetic disorders, including lymphedema-distichiasis syndrome. NGS genetic testing can help confirm a diagnosis of lymphedema-distichiasis syndrome in individuals with characteristic symptoms. It can also be used for carrier testing in family members of affected individuals and for prenatal testing in pregnancies at risk for this syndrome.

Overall, FOXC2 gene NGS genetic testing plays a crucial role in the diagnosis and management of lymphedema-distichiasis syndrome, allowing for early detection, genetic counseling, and appropriate medical interventions.

Test Name	FOXC2 Gene Lymphedema-distichiasis syndrome Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FOXC2 Gene Lymphedema-distichiasis syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXC2 Gene Lymphedema-distichiasis syndrome NGS Genetic DNA Test gene FOXC2
Test Details	The FOXC2 gene is a gene that provides instructions for making a protein called forkhead box C2. This protein is involved in the development of various tissues and organs, including the lymphatic system. Mutations in the FOXC2 gene can lead to a condition called lymphedema-distichiasis syndrome. Lymphedema-distichiasis syndrome is a rare genetic disorder characterized by the abnormal swelling of the limbs due to impaired lymphatic drainage. Distichiasis refers to the presence of extra eyelashes along the eyelid margin. Other features of this syndrome may include heart defects, cleft palate, and varicose veins. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the FOXC2 gene. It is a powerful tool that can detect mutations or variations in the DNA sequence of genes associated with various genetic disorders, including lymphedema-distichiasis syndrome. NGS genetic testing can help confirm a diagnosis of lymphedema-distichiasis syndrome in individuals with characteristic symptoms. It can also be used for carrier testing in family members of affected individuals and for prenatal testing in pregnancies at risk for this syndrome. Overall, FOXC2 gene NGS genetic testing plays a crucial role in the diagnosis and management of lymphedema-distichiasis syndrome, allowing for early detection, genetic counseling, and appropriate medical interventions.